Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Neurooncol. 2015 Jun 25;124(3):365–372. doi: 10.1007/s11060-015-1853-7

Figure 2.

Figure 2

Survival of control and treated athymic nude rats and mice after a single dose of VB-111. (A) Nude rats bearing U87MG (9 control and 10 treated rats). (B) Nude mice bearing U251 (10 mice for each group). Survival distributions for both xenograft models showed a significant difference (p<0.05) in favor of treatment with a 10 day increase in median survival in the VB-111 treated rats and a 13 day increase in the VB-111 treated mice versus respective control.